ALLO vs TEL · rev $22.0K vs P/E 39, rev $17.26B
Allogene Therapeutics Inc (ALLO) versus TE Connectivity Ltd (TEL) — a side-by-side from cached financials, not a winner call.
Allogene Therapeutics Inc (ALLO) is a biotechnology company listed on US.
TE Connectivity Ltd (TEL) is a electronic components company listed on US.
Latest reported ALLO revenue for 2024-12-31 was $22.0K. Net income was -$257.6M. Revenue was down 76.8% from 2023-12-31 to 2024-12-31. ALLO currently screens at market cap $258.1M.
Latest reported TEL revenue for 2025-09-26 was $17.26B. Net income was $1.84B. Revenue was up 8.9% from 2024-09-27 to 2025-09-26. TEL currently screens at market cap $52.52B and trailing P/E 38.5.
ALLO currently screens at market cap $258.1M. TEL currently screens at market cap $52.52B and trailing P/E 38.5.
Not investment advice. Open the ALLO and TEL stock pages for the full models.
Not investment advice.